James C Coons

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 18

Top Topics

Left Ventricular

Pulmonary Arterial Hypertension

Oral Anticoagulants

Top Venues

Pharmacotherapy

Journal of clinical medicine

Journal of cardiovascular pharmacology and therapeutics

Therapeutic advances in respiratory disease

This page only lists publications with an associated author ORCID identifier.

Publications

James C Coons, Vamshi Ruthwik Anupindi, Riddhi Doshi, Mitchell DeKoven, Feng Dai, Cristina Russ, Robert Stellhorn, Dong Cheng, Liucheng Shi, Serina Deeba, Dionne M Hines
Post-Discharge Treatment Patterns among Patients Treated with Apixaban or Warfarin during Hospitalization for Venous Thromboembolism (VTE). Journal of clinical medicine 13 (12) (2024)
James C Coons, Vamshi Ruthwik Anupindi, Riddhi Doshi, Mitchell DeKoven, Feng Dai, Cristina Russ, Robert Stellhorn, Dong Cheng, Liucheng Shi, Serina Deeba, Dionne M Hines
Post-Discharge Treatment Patterns among Patients Treated with Apixaban or Warfarin during Hospitalization for Venous Thromboembolism (VTE). Journal of clinical medicine 13 (12) (2024)
James C Coons, Philip E Empey
Pharmacogenomics in the Management of Pulmonary Arterial Hypertension: Current Perspectives. Pharmacogenomics and personalized medicine 16 (2023)
Elizabeth M Foster, Danine Sullinger, James C Coons
Management Considerations for Pulmonary Arterial Hypertension Pharmacotherapy in the Intensive Care Unit. Pharmacy (Basel, Switzerland) 11 (5) (2023)
James C Coons, James M Stevenson, Ami Patel, A J Conrad Smith, Linda Prebehalla, Philip E Empey
Antiplatelet Therapy and Bleeding Outcomes With CYP2C19 Genotyping. Journal of cardiovascular pharmacology and therapeutics 27 (2022)
Larisa H Cavallari, Nita A Limdi, Amber L Beitelshees, James C Lee, Julio D Duarte, Francesco Franchi, Sony Tuteja, Jay Giri, Philip E Empey, Rolf P Kreutz, Todd C Skaar, John M Allen, James C Coons, Yan Gong, Caitrin W McDonough, James M Stevenson, Cameron D Thomas, Julie A Johnson, George A Stouffer, Dominick J Angiolillo, And Craig R Lee, null null
Evaluation of Potential Racial Disparities in CYP2C19-Guided P2Y 12 Inhibitor Prescribing After Percutaneous Coronary Intervention. Clinical pharmacology and therapeutics (2022)
James C Coons, Karryn Crisamore, Solomon Adams, Ashley Modany, Marc A Simon, Wenchen Zhao, Imam H Shaik, Raman Venkataramanan, Philip E Empey
A pilot study of oral treprostinil pharmacogenomics and treatment persistence in patients with pulmonary arterial hypertension. Therapeutic advances in respiratory disease 15 (2022)
James C Coons, James M Stevenson, Ami Patel, A J Conrad Smith, Linda Prebehalla, Philip E Empey
Antiplatelet Therapy and Bleeding Outcomes With CYP2C19 Genotyping. Journal of cardiovascular pharmacology and therapeutics 27 (2022)
Amber L Beitelshees, Cameron D Thomas, Philip E Empey, George A Stouffer, Dominick J Angiolillo, Francesco Franchi, Sony Tuteja, Nita A Limdi, James C Lee, Julio D Duarte, Rolf P Kreutz, Todd C Skaar, James C Coons, Jay S Giri, Caitrin W McDonough, Rachel Rowland, James M Stevenson, Thuy Nhu Thai, Mark R Vesely, Jacob T Wellen, Julie A Johnson, Almut G Winterstein, Larisa H Cavallari, And Craig R Lee, null null
CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings. Journal of the American Heart Association 11 (4) (2022)
Evan M White, James C Coons
Direct Oral Anticoagulant Use in Special Populations: Elderly, Obesity, and Renal Failure. Current cardiology reports 23 (4) (2021)
James C Coons, Lauren Albert, Andrea Bejjani, Carlo J Iasella
Effectiveness and Safety of Direct Oral Anticoagulants versus Warfarin in Obese Patients with Acute Venous Thromboembolism. Pharmacotherapy 40 (3) (2020)
Marissa N Levito, James C Coons, Margaret M Verrico, Adrienne Szymkowiak, Brianna Legler, Eric J Dueweke, Sandra L Kane-Gill
A Systemwide Approach for Navigating the Dilemma of Oral Factor Xa Inhibitor Interference With Unfractionated Heparin Anti-Factor Xa Concentrations. The Annals of pharmacotherapy 55 (5) (2020)
Brent N Reed, Robert J DiDomenico, J Erin Allender, James C Coons, Jenna F Cox, Daniel Johnson, Carrie S Oliphant, Douglas L Jennings
Survey of Anticoagulation Practices with the Impella Percutaneous Ventricular Assist Device at High-Volume Centers. Journal of interventional cardiology 2019 (2019)
James C Coons, Taylor Miller
Extended-release oral treprostinil in the management of pulmonary arterial hypertension: clinical evidence and experience. Therapeutic advances in respiratory disease 12 (2019)
Kazuhiko Kido, James C Coons
Efficacy and Safety of the Use of Pulmonary Arterial Hypertension Pharmacotherapy in Patients with Pulmonary Hypertension Secondary to Left Heart Disease: A Systematic Review. Pharmacotherapy 39 (9) (2019)
Karryn R Crisamore, Thomas D Nolin, James C Coons, Philip E Empey
Engaging and Empowering Stakeholders to Advance Pharmacogenomics. Clinical pharmacology and therapeutics 106 (2) (2019)
James C Coons, Carlo J Iasella, Megan Thornberg, Mary Grace Fitzmaurice, Kimberly Goehring, Lindsay Jablonski, Dominic Leader, Abby Meyer, Hangil Seo, Neal J Benedict, Roy E Smith
Clinical outcomes with unfractionated heparin monitored by anti-factor Xa vs. activated partial Thromboplastin time. American journal of hematology 94 (9) (2019)
J Erin Allender, Brent N Reed, Jenna L Foster, Jeremy D Moretz, Carrie S Oliphant, Douglas L Jennings, Robert J DiDomenico, James C Coons
Pharmacologic Considerations in the Management of Patients Receiving Left Ventricular Percutaneous Mechanical Circulatory Support. Pharmacotherapy 37 (10) (2017)